Definition, epidemiology, course, and prognosis of COPD

Clinical Cornerstone

Volumn 5, Issue 1, 2003, Pages 1-10

  Petty, Thomas L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NICOTINE; PHOSPHODIOTENASE 4 INHIBITOR; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ADULT; AGE; CALCULATION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DYSPNEA; EARLY DIAGNOSIS; EXERCISE; HEALTH CARE COST; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH PROGRAM; HUMAN; INCIDENCE; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REVIEW; SMOKING; SOCIETY; SPIROMETRY; SYMPTOM; WHEEZING;

EID: 0037269667     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(03)90003-2     Document Type: Article

References (20)

1. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
2. NHLBI, Data Fact Sheet (May 2001).
3. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. JAMA. 1997;277:246-253.
4. Petty TL. Strategies in preserving lung health and preventing COPD and associated diseases: The National Lung Health Education Program (NLHEP). Chest. 1998;113(suppl):123S-163S.
5. Pauwels RA, Buist AS, Calverly PM, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163: 1256-1276.
6. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults. A consensus statement from the National Lung Health Education Program. Chest. 2000;117: 1146-1161.
7. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States. (Data from the National Health and Nutrition Examination Survey, 1988-1994). Arch Intern Med. 2000;160:1683-1689.
8. Silvers GW, Petty TL, Stanford RE. Elastic recoil changes in early emphysema. Thorax. 1980;35: 490-495.
9. Petty TL, Silvers GW, Stanford RE. Small airway disease is associated with elastic recoil changes in excised human lungs. Am Rev Respir Dis. 1984;130: 42-45.
10. Petty TL. The early diagnosis of lung cancer. Dis Mon. 2001;47:204-264.
11. Lippmann M, Fein A. Pulmonary embolism in the patient with chronic obstructive pulmonary disease. A diagnostic dilemma. Chest. 1981;79:39-42.
12. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002;121(suppl):127S-130S.
13. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269-280.
14. Petty TL. COPD in perspective. Chest. 2002;121 (suppl):116S-120S.
15. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med. 2000;162:917-919.
16. Guyatt GH, Townsend M, Pugsley SO, et al. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity and quality of life. Am Rev Respir Dis. 1987;135:1069-1074.
17. American Thoracic Society. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995; 152(suppl):78S-83S.
18. Guyatt GA, Townsend M, Nogradi S, et al. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy. Arch Intern Med. 1988;148: 1949-1952.
19. Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium versus salmeterol. Chest. 2002;122:47-55.
20. 1. The Lung Health Study. JAMA. 1994;272: 1497-1505.